PMS21 COST-EFFECTIVENESS OF RITUXIMAB VS ADALIMUMAB IN THE TREATMENT OF MODERATE TO SEVERE RHEUMATOID ARTHRITIS

May 1, 2010, 00:00 AM
10.1016/S1098-3015(10)72609-7
https://www.valueinhealthjournal.com/article/S1098-3015(10)72609-7/fulltext
Section Title :
Section Order : 150
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)72609-7&doi=10.1016/S1098-3015(10)72609-7
HEOR Topics :
Tags :
Regions :